1 |
Campbell B, De Silva DA, Macleod MR, et al. Ischaemic stroke [J]. Nat Rev Dis Primers, 2019, 5(1): 71.
|
2 |
Collaborators G, Feigin VL, Nguyen G, et al. Global,regional,and Country-Specific lifetime risks of stroke,1990 and 2016 [J]. N Engl J Med, 2018, 379(25): 2429-2437.
|
3 |
夏章,姜莹莹,董文兰,等. 2004-2018年中国老年居民慢性非传染性疾病死亡水平与变化趋势 [J].中华流行病学杂志, 2021, 42(3): 499-507.
|
4 |
王拥军,李子孝,谷鸿秋,等.中国卒中报告2019(中文版)(1) [J].中国卒中杂志, 2020, 15(10): 1037-1043.
|
5 |
王陇德.脑卒中筛查与防治工程:关注动脉硬化的高危因素——探求尽快降低我国脑卒中发病、死亡和伤残之策 [J].中国医学前沿杂志:电子版, 2011, 3(3): 1-3.
|
6 |
Anon . Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis [J]. Am J Med, 1993, 94(6): 646-650.
|
7 |
Bouvard B, Annweiler C, Legrand E. Osteoporosis in older adults[J]. Joint Bone Spine, 2021, 88(3): 105135.
|
8 |
Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures [J]. Osteoporos Int, 2006, 17(12): 1726-1733.
|
9 |
刘雅克,王洪,朱鸣镝,等.老年髋部骨折术后对侧再骨折的随访研究 [J].中华老年骨科与康复电子杂志, 2017, 3(4): 205-209.
|
10 |
冯宪煊,施慧鹏,白跃宏.老年骨质疏松性骨折的康复治疗 [J].中华老年骨科与康复电子杂志, 2018, 4(1): 48-51.
|
11 |
Moayyeri A, Alrawi YA, Myint PK. The complex mutual connection between stroke and bone health [J]. Arch Biochem Biophys, 2010, 503(1): 153-159.
|
12 |
王银河,刘伟林,朱秀芬,等.老年人群脑卒中后骨质疏松的机制和治疗 [J].实用老年医学, 2017, 31(8): 718-722.
|
13 |
Zhou R, Liu D, Li R, et al. Low bone mass is associated with stroke in Chinese postmenopausal women: the Chongqing osteoporosis study [J]. Cell Biochem Biophys, 2015, 71(3): 1695-1701.
|
14 |
Lin CH, Chang WC, Kuo CN, et al. A population-based five-year study on the risk of stroke in patients with osteoporosis in Taiwan[J]. Bone, 2015, 72: 9-13.
|
15 |
Minn YK, Suk SH, Do SY. Osteoporosis as an Independent risk factor for silent brain infarction and white matter changes in men and women: the PRESENT project [J]. Osteoporos Int, 2014, 25(10): 2465-2469.
|
16 |
Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets [J]. Nucleic Acids Res, 2019, 47(D1): D607-D613.
|
17 |
韩亚军,帖小佳.伊力哈木·托合提.中国中老年人骨质疏松症患病率的Meta分析 [J].中国组织工程研究, 2014, 18(07): 1129-1134.
|
18 |
贺丽英,孙蕴.要文娟,潘克梫.2010-2016年中国老年人骨质疏松症患病率Meta分析 [J].中国骨质疏松杂志, 2016, 22(12): 1590-1596.
|
19 |
Wu CH, Liou TH, Hsiao PL, et al. Contribution of ischemic stroke to hip fracture risk and the influence of gender difference [J]. Arch Phys Med Rehabil, 2011, 92(12): 1987-1991.
|
20 |
Wang HP, Sung SF, Yang HY, et al. Associations between stroke type, stroke severity, and pre-stroke osteoporosis with the risk of post-stroke fracture: A nationwide population-based study [J]. J Neurol Sci, 2021, 427: 117512.
|
21 |
Myint PK, Clark AB, Kwok CS, et al. Bone mineral density and incidence of stroke: European prospective investigation into cancer-norfolk population-based study, systematic review, and meta-analysis[J]. Stroke, 2014, 45(2): 373-382.
|
22 |
Arron JR, Choi Y. Bone versus immune system [J]. Nature, 2000, 408(6812): 535-536.
|
23 |
Rauner M, Sipos W, Thiele S, et al. Advances in osteoimmunology: pathophysiologic concepts and treatment opportunities [J]. Int Arch Allergy Immunol, 2013, 160(2): 114-125.
|
24 |
Wang YN, Liu S, Jia T, et al. T cell protein tyrosine phosphatase in osteoimmunology [J]. Front Immunol, 2021, 12: 620333.
|
25 |
李子怡,李玉坤. OPG/RANK/RANKL信号通路在骨质疏松症中的研究进展和应用 [J].中华老年骨科与康复电子杂志, 2017, 3(2): 124-128.
|
26 |
Hermann DM, Liesz A, Dzyubenko E. Implications of immune responses for ischemic brain injury and stroke recovery [J]. Brain Behav Immun, 2021, 96: 292-294.
|
27 |
Iadecola C, Buckwalter MS, Anrather J. Immune responses to stroke: mechanisms, modulation, and therapeutic potential [J]. J Clin Invest, 2020, 130(6): 2777-2788.
|
28 |
Rayasam A, Hsu M, Kijak JA, et al. Immune responses in stroke: how the immune system contributes to damage and healing after stroke and how this knowledge could be translated to better cures? [J]. Immunology, 2018, 154(3): 363-376.
|
29 |
Romero OA, Vilarrubi A, Alburquerque-Bejar JJ, et al. SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade [J]. Nat Commun, 2021, 12(1): 4319.
|
30 |
Qi X, Qiu J, Chang J, et al. Brg1 restrains the pro-inflammatory properties of ILC3s and modulates intestinal immunity [J]. Mucosal Immunol, 2021, 14(1): 38-52.
|
31 |
Nakatochi M, Ichihara S, Yamamoto K, et al. Epigenome-wide association of myocardial infarction with DNA methylation sites at loci related to cardiovascular disease [J]. Clin Epigenetics, 2017, 9: 54.
|
32 |
Van Wijnen AJ, Bagheri L, Badreldin AA, et al. Biological functions of chromobox (CBX) proteins in stem cell self-renewal, lineage-commitment, cancer and development [J]. Bone, 2021, 143: 115659.
|
33 |
Eyileten C, Wicik Z, De Rosa SA, et al. MicroRNAs as diagnostic and prognostic biomarkers in ischemic Stroke- A comprehensive review and bioinformatic analysis [J]. Cells, 2018, 7(12): 249.
|
34 |
Ju ZR, Wang HJ, Ma XJ, et al. HIRA gene is lower expressed in the myocardium of patients with tetralogy of fallot [J]. Chin Med J (Engl), 2016, 129(20): 2403-2408.
|
35 |
Xia B, Li Y, Zhou J, et al. Identification of potential pathogenic genes associated with osteoporosis [J]. Bone Joint Res, 2017, 6(12): 640-648.
|
36 |
Fann DY, Lim YA, Cheng YL, et al. Evidence that NF- κB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke [J]. Mol Neurobiol, 2018, 55(2): 1082-1096.
|
37 |
An Y, Zhang H, Wang C, et al. Activation of ROS/MAPKs/NF-κB/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis [J]. FASEB J, 2019, 33(11): 12515-12527.
|